Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M118,650Revenue $M47,999Net Margin (%)8.9Z-Score2.7
Enterprise Value $M124,587EPS $4.7Operating Margin %12.3F-Score7
P/E(ttm))29.9Cash Flow Per Share $0Pre-tax Margin (%)11.9Higher ROA y-yY
Price/Book5.410-y EBITDA Growth Rate %2.2Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %4.7Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %9.3ROA % (ttm)6.6Higher Current Ratio y-yY
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)18.0Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M827ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 147.737%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 147.739%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 147.7338%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-12-31 Reduce-0.21%$83.28 - $96.38
($89.59)
$ 147.7365%Reduce -21.2%2,044,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 147.7392%New holding, 72838 sh.72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 147.73146%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 147.73180%Sold Out0
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 147.73180%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 147.73180%New holding, 6500 sh.6,500
BAYRYJohn Keeley 2008-03-31 Sold Out -0.01%$69.76 - $92.41
($78.8)
$ 147.7388%Sold Out0
BAYRYJohn Keeley 2007-09-30 Buy $68.04 - $79.44
($75.7)
$ 147.7395%New holding, 11000 sh.11,000
BAYRYVanguard Health Care Fund 2007-03-31 Reduce-1.27%$52.14 - $61.01
($56.7)
$ 147.73160%Reduce -22.24%5,944,656
BAYRYVanguard Health Care Fund 2006-09-30 Add1.48%$45.67 - $50.95
($48.9)
$ 147.73202%Add 1811.16%7,644,656
BAYRYKen Fisher 2006-04-27 Buy Premium Member Access $40 $ 147.73269%P/E=12
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BAYRY Ken Fisher 2014-12-312,493,4190.30.7-0.71%
Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BAYRY :

    Quarterly/Annual Reports about BAYRY:

      News about BAYRY:

      Articles On GuruFocus.com
      Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
      Zoetis Will Benefit from Industry Trends Oct 07 2014 
      Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
      Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
      We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
      Mallinckrodt Acquired San Diego Pharma and Much More Mar 21 2014 
      Ken Fisher for Forbes - 5 Fantastic Stocks for Fretters Jun 26 2013 
      Pfizer: A Strong Stock for 2013 Apr 20 2012 
      Maxygen Inc. (MAXY): A Magic Formula Stock to Avoid Feb 05 2009 

      More From Our Partners
      Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog Feb 27 2015 - ZACKS

      More From Other Websites
      Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog Feb 27 2015
      Bayer is 'focusing on life sciences' Feb 26 2015
      Bayer R&D budget to increase Feb 26 2015
      Financial News Conference -- Address by Dr. Marijn Dekkers -- Chairman of the Board of Management Feb 26 2015
      Financial News Conference -- Address by Johannes Dietsch -- Member of the Board of Management Feb 26 2015
      Dr. Richard Pott to be Chairman of the Supervisory Board of Bayer MaterialScience Feb 25 2015
      Bayer proposes increased dividend for 2014 of EUR 2.25 per share -- Total dividend payout rises 7.1... Feb 25 2015
      Avago, Jazz, MercadoLibre Build Bases Before Q4 Reports Feb 23 2015
      A 'Great Entry Point' for AbbVie; Pfizer a 'Value Creation Machine' Feb 20 2015
      Regeneron's Eylea Tops Diabetic Macular Edema Study - Analyst Blog Feb 19 2015
      Improving innovation and sustainability in the apparel and footwear industry -- Bayer... Feb 19 2015
      Regeneron Beats on Q4 Earnings Driven by Eylea Sales (revised) - Analyst Blog Feb 18 2015
      Bayer CropScience hosts Cereal Future Forum in Brussels -- Leading cereal experts discussing... Feb 18 2015
      Bayer Crop Science’s initiative celebrates 10th anniversary at Fruit Logistica 2015 in Berlin: --... Feb 11 2015
      Mylan Faces Patent Infringement Lawsuit for Nexavar - Analyst Blog Feb 10 2015
      Regeneron Beats on Q4 Earnings Driven by Eylea Sales - Analyst Blog Feb 10 2015
      Will Regeneron (REGN) Beat Q4 Earnings on Eylea Sales? - Analyst Blog Feb 09 2015
      Firmado un nuevo acuerdo de colaboración -- Bayer CropScience y GLOBALG.A.P. intensifican su... Feb 05 2015
      New collaboration agreement signed: -- Bayer CropScience and GLOBALG.A.P. intensify their... Feb 05 2015
      Bayer MaterialScience at UTECH 2015 -- Thinking in Life Cycles -- Invitation to join in developing... Feb 05 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK